University of Texas MD Anderson Cancer Center - Proton Therapy Center

Broaddus & Associates is serving on the project delivery team for the $159M expansion of the Proton Therapy Center (PTC) for The University of Texas MD Anderson Cancer Center (UTMDACC). The project, located in the Texas Medical Center in Houston, TX, will more than double the center’s size to more than 160,000 SF (almost the size of three football fields), allowing more patients greater access to the most advanced and precise form of radiation therapy.

The PTC expansion will allow the facility to include a total of eight radiation therapy machines that rotate 360 degrees around a patient to deliver a proton beam. The new machines, developed by Hitachi, will deliver intensity-modulated proton therapy, the most precise form of image-guided radiation therapy available. The expansion also will include an additional synchrotron, the massive accelerator that creates the proton beam, as well as rooms with improved design for a better patient experience. Proton therapy is an advanced type of radiation treatment that uses a beam of protons to deliver radiation directly to the tumor, destroying cancer cells while sparing healthy tissue. Since opening in 2006, the PTC has treated more than 9,000 patients from across the world within its current 73,500 SF facility.

The Broaddus & Associates team is embedded with the UTMDACC facilities team providing project management services. This engagement represents a continued relationship with UTMDACC, as our team has provided project management and planning services for a variety of UTMDACC healthcare and research facilities in the Texas Medical Center, Smithville, and Bastrop. The estimated completion of the new building is November 2023.